Skip to main content
SpringerLink
Log in
Book cover

Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment

  • Book
  • © 1994

Overview

Editors:
  1. Roberto L. Ceriani

    1. Cancer Research Fund of Contra Costa, Walnut Creek, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 353)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Breast Mucin and Associated Antigens in Diagnosis and Therapy

    • Jerry A. Peterson, Roberto L. Ceriani
    Pages 1-8

  3. Peptide Epitopes in Breast Cancer Mucins

    • Pei-Xiang Xing, Vasso Apostolopoulos, Joe Trapani, Julie Prenzoska, Ian F. C. McKenzie
    Pages 9-16

  4. Does a Novel form of the Breast Cancer Marker Protein, MUC1, Act as a Receptor Molecule that Modulates Signal Transduction?

    • Daniel H. Wreschner, Sheila Zrihan-Licht, Amos Baruch, Dalit Sagiv, Mor-li Hartman, Nechama Smorodinsky et al.
    Pages 17-26

  5. Cancer Metastasis Determined by Carbohydrate-Mediated Cell Adhesion

    • Tatsuro Irimura
    Pages 27-34

  6. Experimental Immunotherapy of Breast Cancer Using Alpha Interferon Conjugated to Monoclonal Antibody Mc5

    • Luciano Ozzello, Carolyn M. De Rosa, David V. Habif Sr., Edward W. Blank, Roberto L. Ceriani, Kari Cantell
    Pages 35-46

  7. Circulating and Tissue Markers in the Longitudinal Management of Breast Cancer Patients

    • Morton K. Schwartz
    Pages 47-53

  8. Engineering of Antibodies for Breast Cancer Therapy: Construction of Chimeric and Humanized Versions of the Murine Monoclonal Antibody BrE-3

    • Joseph R. Couto, Edward W. Blank, Jerry A. Peterson, Radwan Kiwan, Roberto L. Ceriani, Eduardo A. Padlan
    Pages 55-59

  9. Humanization of an Anti-Mucin Antibody for Breast and Ovarian Cancer Therapy

    • T. S. Baker, H. M. Caskey-Finney, D. J. King, A. D. G. Lawson, A. Lyons, A. Mountain et al.
    Pages 61-82

  10. Towards an Immunotherapy for p185HER2 Overexpressing Tumors

    • Paul Carter, Maria L. Rodrigues, Gail D. Lewis, Irene Figari, M. Refaat Shalaby
    Pages 83-94

  11. Branching N-Linked Oligosaccharides in Breast Cancer

    • James W. Dennis, Bernard Fernandez, Bozena Korczak, Paul Goss, Michael Baker
    Pages 95-104

  12. Specificity of the IgG Response in Mice and Human Breast Cancer Patients Following Immunization Against Synthetic Sialyl-Tn, An Epitope with Possible Functional Significance in Metastasis

    • B. Michael Longenecker, Mark Reddish, Rao Koganty, Grant D. MacLean
    Pages 105-124

  13. Vaccination Against Breast Cancer — Studies in an Animal Model

    • Nechama I. Smorodinsky, Ronit Yarden, Lior Carmon, Daniel H. Wreschner, Iafa Keydar, Mara Hareuveni
    Pages 125-137

  14. Anti-Idiotype Antibodies as Potential Therapeutic Agents for Human Breast Cancer

    • Malaya Bhattacharya-Chatterjee, Ewe Mrozek, Sonjoy Mukerjee, Roberto L. Ceriani, Heinz Kohler, Kenneth A. Foon
    Pages 139-148

  15. The Simultaneous Expression of c-erbB-2 Oncoprotein and Laminin Receptor on Primary Breast Tumors has a Predicting Potential Analogous to that of The Lymph Node Status

    • Maria I. Colnaghi
    Pages 149-154

  16. Multivariate Prognostic Model for Infiltrating Ductal Carcinoma of the Breast in the Axillary Node-Free Patient

    • Roberto L. Ceriani, Frank Baratta, Ramon J. Gaslonde, Carolyn M. De Rosa, Luciano Ozzello
    Pages 155-167

  17. The Use of Monoclonal Antibody Immunoconjugates in Cancer Therapy

    • Geoffrey A. Pietersz, Kenia Krauer, Ian F. C. McKenzie
    Pages 169-179

  18. Radioimmunolocalization of Breast Cancer Using BrE-3 Monoclonal Antibody

    • Elissa L. Kramer, Sally J. DeNardo, Leonard Liebes, Marilyn E. Noz, Linda Kroger, Stephan D. Glenn et al.
    Pages 181-192

  19. Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study

    • Kapil Dhingra, Daniel Booser, Aman Buzdar, Martin Raber, Lia Gutierrez, Gabriel Hortobagyi et al.
    Pages 193-202

  20. Overview of Radioimmunotherapy in Advanced Breast Cancer Using I-131 Chimeric L6

    • S J. DeNardo, L. F. O’Grady, C. M. Richman, G. L. DeNardo
    Pages 203-211
Back to top

Keywords

About this book

Today, advances in the area of immunology and breast cancer are made at an increasing rate, yielding an amount of information that can become unwieldy. The opportunity for scientists in this area of research to gather together to exchange results and working hypotheses represents, in my belief, a very attractive proposition. With this in mind, these workshops have been convened with two year intervals for the last ten years. In each of them, selected topics have been highlighted. The present workshop underscores the large advancements made in the molecular biology of both breast cancer associated antigens and their corresponding antibodies. Understanding the genetic information for the expression of these antigens has been recently advanced leading to preparation of molecularly engineered reagents for use in vaccination, serum assays, and immunizations for novel antibody production. In the anti-breast cancer antibody field the availability of molecular engineering approaches to humanize murine antibodies has induced intense interest in the creation of less immunogenic antibody forms that are now available for clinical testing. Clinical studies using anti-breast murine antibody continue to be carried out and are presented at this meeting establishing a base line for safety and efficaciousness in imaging and immunotherapy that it is hoped will be superseded by the humanized forms. Basic immunology and immunochemistry studies in breast cancer are also included in this workshop that demonstrate the fast pace at which this research is advancing in many laboratories worldwide.

Editors and Affiliations

  • Cancer Research Fund of Contra Costa, Walnut Creek, USA

    Roberto L. Ceriani

Bibliographic Information

  • Book Title: Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment

  • Editors: Roberto L. Ceriani

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4615-2443-4

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 1994

  • Hardcover ISBN: 978-0-306-44720-4Published: 31 July 1994

  • Softcover ISBN: 978-1-4613-6038-4Published: 23 October 2012

  • eBook ISBN: 978-1-4615-2443-4Published: 06 December 2012

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XI, 222

  • Topics: Immunology, Biochemistry, general, Biotechnology

Publish with us

Policies and ethics

Back to top

Search

Navigation